Apr 18, 2023 / 01:30PM GMT
David Joshua Saxon - Needham & Company, LLC, Research Division - Senior Analyst
Good morning, everyone. Thanks for joining us at the 22nd Annual Needham Healthcare Conference. My name is David Saxon. I'm one of the analysts on the med tech equity research team here at Needham & Company. Pleased to have with me today, Azenta's CEO, Steve Schwartz; and CFO, Lindon Robertson. They'll be opening with an introductory presentation, and then we'll follow up with a Q&A session. If you have any questions that you'd like to ask, you can submit them electronically through the Needham conference website or you can feel free to e-mail them to me at [email protected], and I'll do my best to fit them in. So with that, Steve and Lindon, I'll turn it over to you.
Stephen S. Schwartz - Azenta, Inc. - CEO, President & Director
Thank you, David. Really pleased to be here at the Needham Virtual Healthcare Conference. So we appreciate the invitation and the chance to speak with everyone today. Lindon and I will split time here on a brief introduction or
Azenta Inc at Needham Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot